TUMBARELLO, MARIO
 Distribuzione geografica
Continente #
EU - Europa 1.369
NA - Nord America 600
AS - Asia 88
OC - Oceania 1
SA - Sud America 1
Totale 2.059
Nazione #
US - Stati Uniti d'America 593
IT - Italia 445
IE - Irlanda 430
SE - Svezia 118
GB - Regno Unito 91
FR - Francia 86
FI - Finlandia 58
DE - Germania 48
CN - Cina 45
RU - Federazione Russa 28
PL - Polonia 20
ES - Italia 17
SG - Singapore 13
UA - Ucraina 12
CA - Canada 7
IN - India 7
HK - Hong Kong 6
NL - Olanda 5
CZ - Repubblica Ceca 4
CH - Svizzera 3
IL - Israele 3
MY - Malesia 2
TR - Turchia 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BR - Brasile 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
PH - Filippine 1
RO - Romania 1
TH - Thailandia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 2.059
Città #
Dublin 413
Chandler 108
Ashburn 82
Southend 73
Siena 70
Florence 61
Helsinki 53
Princeton 40
Fairfield 38
New York 35
Moscow 27
Milan 26
Rome 25
Shanghai 22
Gdynia 18
Málaga 16
Boardman 13
Woodbridge 13
London 12
Washington 11
Comun Nuovo 10
San Diego 10
Wilmington 10
Jacksonville 9
Seattle 9
Fremont 8
Paris 8
Brescia 7
Chicago 7
Singapore 7
Bacoli 6
Carrara 6
Catania 6
Hong Kong 6
Houston 6
Rubano 6
Bergamo 5
Grosseto 5
Migliarino 5
Montreal 5
Verona 5
Ann Arbor 4
Fiesole 4
Lappeenranta 4
Los Angeles 4
Palermo 4
Salerno 4
West Jordan 4
Amsterdam 3
Bonndorf 3
Borgonovo Val Tidone 3
Cambridge 3
Guagnano 3
Lanciano 3
Massa 3
Nanjing 3
Naples 3
Nuremberg 3
Olomouc 3
Pistoia 3
Rieti 3
Signa 3
Wustrow 3
Bangalore 2
Berlin 2
Bologna 2
Bonn 2
Campi Bisenzio 2
Carbonara di Nola 2
Genoa 2
Guangzhou 2
Hebei 2
Hyderabad 2
Livorno 2
Mumbai 2
Omaha 2
Orléans 2
Osimo 2
Padova 2
Pedrengo 2
Pian di Scò 2
Pomarance 2
Rosignano Marittimo 2
Saint-Fons 2
San Francisco 2
Sanaa 2
Santa Maria a Monte 2
Sinalunga 2
Stezzano 2
Toronto 2
Watford 2
Wettingen 2
Aubervilliers 1
Baku 1
Barberino di Mugello 1
Bari 1
Beijing 1
Brussels 1
Buffalo 1
Bulciago 1
Totale 1.441
Nome #
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 122
Mapping the human genetic architecture of COVID-19 106
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC). 95
Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients 93
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 93
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 93
A first update on mapping the human genetic architecture of COVID-19 87
Pathogen-sugar interactions revealed by universal saturation transfer analysis 87
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 75
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 71
An explainable model of host genetic interactions linked to COVID-19 severity 70
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 66
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study. 66
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 55
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) 52
null 48
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study) 48
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement 47
Whole-genome sequencing reveals host factors underlying critical COVID-19 43
Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative bacilli: A review of the emerging data 43
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 41
ACKNOWLEDGEMENT OF REVIEWERS 41
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 41
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 41
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 40
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 37
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants 37
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 31
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 30
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 30
Factors associated with inadequate intravenous colistin dosages: Post hoc analysis of a multicenter, cross-sectional study 28
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 25
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 25
An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE 24
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 24
Posterior Reversible Encephalopathy Syndrome After Intramuscular Oxygen-Ozone Therapy 24
null 23
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 23
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients. 22
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 21
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 19
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia 19
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 18
Use of colistin in adult patients: A cross-sectional study 18
SARS-CoV-2 infection in a highly experienced person living with HIV 17
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 13
Totale 2.172
Categoria #
all - tutte 14.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 0 5
2019/202036 6 1 3 7 2 2 3 5 2 3 0 2
2020/202134 0 5 0 3 0 5 0 7 4 2 5 3
2021/2022282 14 4 1 5 3 2 30 56 13 23 47 84
2022/2023756 35 79 83 61 35 101 97 87 66 36 57 19
2023/20241.027 50 37 98 66 49 199 297 54 9 37 44 87
Totale 2.172